Gian Luca Araldi

Principal investigator.

Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$3.4MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20172023
AwardsPatents
Federal awards as principal investigator

7 awards · $3.4M

DateAgencyAwardAmountCompany
Jul 25, 2023NIHSBIR Phase I
USE OF DYRK1A/B KINASE INHIBITORS FOR THE TREATMENT OF LIVER DISEASES
$349KAvanti Biosciences Inc
Feb 26, 2020NIHSBIR Phase II
Development of DYRK1A allosteric modulator for the treatment of Alzheimer's Disease
$376KAvanti Biosciences Inc
Aug 31, 2019NIHSBIR Phase II
Development of DYRK1A allosteric modulator for the treatment of Alzheimer’s Disease
$350KAvanti Biosciences Inc
Jun 19, 2019NIHSBIR Phase I
DYRK1A inhibitors as therapeutic approach to Tau hyper-phosphorylation for treatment of Alzheimer disease and other CNS disorders
$449KAvanti Biosciences Inc
May 2, 2019NIHSBIR Phase II
Development of DYRK1A allosteric modulator for the treatment of Alzheimer’s Disease
$971KAvanti Biosciences Inc
Jul 17, 2018NIHSBIR Phase I
Development of novel prodrugs targeting Glutamate Dehydrogenase (GDH) for the treatment of congenital hyperinsulinemia disorder including Hyperinsulinemia-Hyperammonemia Syndrome (HHS) and SCHAD-HI.
$299KAvanti Biosciences Inc
Aug 15, 2017NIHSBIR Phase II
Development of DYRK1A allosteric modulator for the treatment of Alzheimer’s Disease
$583KAvanti Biosciences Inc
Patents

1 patents as inventor

Matched by the first inventor’s name and the patent’s company.

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#515
Awards as PI#250
Patents#273
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.